Amgen Financial Statements From 2010 to 2026

Stocks . Germany . 
Stock . Amgen Inc
AMG Stock   310.20  22.80  7.93%   
Analyzing historical trends in various income statement and balance sheet accounts from Amgen's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Amgen's valuation are summarized below:
Market Capitalization
105.2 B
Enterprise Value Revenue
6.1984
There are currently sixty-three fundamental signals for Amgen Inc that can be evaluated and compared over time across rivals. All traders should validate Amgen's prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction.

Amgen Total Revenue

28.39 Billion

Check Amgen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amgen's main balance sheet or income statement drivers, such as Tax Provision of 443.7 M, Interest Income of 218.9 M or Interest Expense of 3.8 B, as well as many indicators such as . Amgen financial statements analysis is a perfect complement when working with Amgen Valuation or Volatility modules.
  
This module can also supplement various Amgen Technical models . Check out the analysis of Amgen Correlation against competitors.

Amgen Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets80.9 B105.6 B77.3 B
Pretty Stable
Total Current Liabilities15.6 B26.6 B13.9 B
Slightly volatile
Total Stockholder Equity9.7 B5.3 B17.8 B
Slightly volatile
Accounts Payable1.6 B2.2 B1.3 B
Slightly volatile
Cash7.9 B13.8 B6.2 B
Slightly volatile
Non Current Assets Total47.5 B72.2 B41 B
Slightly volatile
Non Currrent Assets Other12 B11.4 B4.6 B
Slightly volatile
Long Term Debt42 B65 B37.2 B
Slightly volatile
Net Receivables5.3 B7.8 B4.4 B
Slightly volatile
Good Will17.3 B21.4 B15.8 B
Slightly volatile
Non Current Liabilities Total52 B72.3 B45.2 B
Slightly volatile
Inventory5.1 B8 B4.2 B
Slightly volatile
Other Current Assets358.2 M377.1 M1.4 B
Slightly volatile
Total Liabilities67.6 B98.9 B59.2 B
Slightly volatile
Short and Long Term Debt1.8 B3.2 B3 B
Slightly volatile
Total Current Assets24.3 B26.1 B35.3 B
Slightly volatile
Non Current Liabilities Other2.1 B2.7 B1.8 B
Slightly volatile
Short Term Debt2.6 B2.7 B3.5 B
Slightly volatile
Intangible Assets18.8 B31.9 B15.7 B
Slightly volatile
Net Debt36.8 B55.3 B34.1 B
Slightly volatile
Common Stock Shares Outstanding468.6 M483.3 M629 M
Slightly volatile
Net Invested Capital56.2 B75.9 B56.7 B
Very volatile
Net Working Capital5.1 B5.3 B23.8 B
Slightly volatile
Capital Stock35.5 B38.6 B32.3 B
Slightly volatile
Property Plant And Equipment Net6 B7.5 B5.3 B
Slightly volatile
Property Plant And Equipment Gross16.2 B19.5 B14.3 B
Slightly volatile

Amgen Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Tax Provision443.7 M467.1 M1.5 B
Pretty Stable
Interest Income218.9 M230.4 M499.3 M
Slightly volatile
Selling General Administrative6.1 B8.2 B5.6 B
Slightly volatile
Total Revenue28.4 B38.4 B25.7 B
Slightly volatile
Gross Profit21.4 B23.7 B19.6 B
Slightly volatile
Operating Income7.2 B6.5 B9 B
Slightly volatile
Net Income From Continuing Ops5 B3.7 B6.6 B
Slightly volatile
EBIT14.1 B14.9 B12.9 B
Slightly volatile
Research Development5 B6.9 B4.5 B
Slightly volatile
Cost Of Revenue15.5 B14.8 B6.6 B
Slightly volatile
Total Operating Expenses18.5 B30.1 B16.4 B
Slightly volatile
Income Before Tax6.4 B4.1 B8.1 B
Slightly volatile
Net Income5 B3.7 B6.6 B
Slightly volatile
EBITDA8.6 B7.9 B11.1 B
Slightly volatile
Reconciled Depreciation3.6 B6.4 B2.9 B
Slightly volatile

Amgen Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation3.5 B6.4 B3 B
Slightly volatile
Dividends Paid4.2 B5.6 B3.7 B
Slightly volatile
Capital Expenditures915.3 M1.3 B863.9 M
Slightly volatile
Total Cash From Operating Activities8.1 B10.3 B10.1 B
Slightly volatile
Net Income5 B3.7 B6.6 B
Slightly volatile
End Period Cash Flow7.9 B13.8 B6.2 B
Slightly volatile
Free Cash Flow7.4 B9.4 B9.7 B
Slightly volatile
Begin Period Cash Flow7.3 B12.6 B5.6 B
Slightly volatile
Stock Based Compensation429.2 M609.5 M361.9 M
Slightly volatile

Amgen Fundamental Market Drivers

About Amgen Financial Statements

Amgen shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Amgen investors may analyze each financial statement separately, they are all interrelated. The changes in Amgen's assets and liabilities, for example, are also reflected in the revenues and expenses on on Amgen's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue38.4 B28.4 B
Cost Of Revenue14.8 B15.5 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Amgen Stock Analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY